Histamine beyond its effects on allergy

Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

ALS currently remains a challenge despite many efforts in performing successful clinical trials and formulating therapeutic solutions. By learning from current failures and striving for success, scientists and clinicians are checking every possibility to search for missing hints and efficacious treatments. Because the disease is very complex and heterogeneous and, moreover, targeting not only motor neurons but also several different cell types including muscle, glial, and immune cells, the right answer to ALS is conceivably a multidrug strategy or the use of broad-spectrum molecules. The aim of the present work is to gather evidence about novel perspectives on ALS pathogenesis and to present recent and innovative paradigms for therapy. In particular, we describe how an old molecule possessing immunomodulatory and neuroprotective functions beyond its recognized effects on allergy, histamine, might have a renewed and far-reaching momentum in ALS.

Original languageEnglish
JournalPharmacology and Therapeutics
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Amyotrophic Lateral Sclerosis
Histamine
Hypersensitivity
Investigational Therapies
Motor Neurons
Therapeutics
Neuroglia
Muscle Cells
Clinical Trials
Learning

Keywords

  • ALS
  • Histamine
  • Microglia
  • Motor neuron
  • Neuroinflammation
  • Personalized medicine
  • SOD1-G93A

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{6ea7fcf9bf4845bb907f555aa84a1699,
title = "Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)",
abstract = "ALS currently remains a challenge despite many efforts in performing successful clinical trials and formulating therapeutic solutions. By learning from current failures and striving for success, scientists and clinicians are checking every possibility to search for missing hints and efficacious treatments. Because the disease is very complex and heterogeneous and, moreover, targeting not only motor neurons but also several different cell types including muscle, glial, and immune cells, the right answer to ALS is conceivably a multidrug strategy or the use of broad-spectrum molecules. The aim of the present work is to gather evidence about novel perspectives on ALS pathogenesis and to present recent and innovative paradigms for therapy. In particular, we describe how an old molecule possessing immunomodulatory and neuroprotective functions beyond its recognized effects on allergy, histamine, might have a renewed and far-reaching momentum in ALS.",
keywords = "ALS, Histamine, Microglia, Motor neuron, Neuroinflammation, Personalized medicine, SOD1-G93A",
author = "Cinzia Volont{\'e} and Savina Apolloni and Mario Sabatelli",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pharmthera.2019.06.006",
language = "English",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Histamine beyond its effects on allergy

T2 - Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)

AU - Volonté, Cinzia

AU - Apolloni, Savina

AU - Sabatelli, Mario

PY - 2019/1/1

Y1 - 2019/1/1

N2 - ALS currently remains a challenge despite many efforts in performing successful clinical trials and formulating therapeutic solutions. By learning from current failures and striving for success, scientists and clinicians are checking every possibility to search for missing hints and efficacious treatments. Because the disease is very complex and heterogeneous and, moreover, targeting not only motor neurons but also several different cell types including muscle, glial, and immune cells, the right answer to ALS is conceivably a multidrug strategy or the use of broad-spectrum molecules. The aim of the present work is to gather evidence about novel perspectives on ALS pathogenesis and to present recent and innovative paradigms for therapy. In particular, we describe how an old molecule possessing immunomodulatory and neuroprotective functions beyond its recognized effects on allergy, histamine, might have a renewed and far-reaching momentum in ALS.

AB - ALS currently remains a challenge despite many efforts in performing successful clinical trials and formulating therapeutic solutions. By learning from current failures and striving for success, scientists and clinicians are checking every possibility to search for missing hints and efficacious treatments. Because the disease is very complex and heterogeneous and, moreover, targeting not only motor neurons but also several different cell types including muscle, glial, and immune cells, the right answer to ALS is conceivably a multidrug strategy or the use of broad-spectrum molecules. The aim of the present work is to gather evidence about novel perspectives on ALS pathogenesis and to present recent and innovative paradigms for therapy. In particular, we describe how an old molecule possessing immunomodulatory and neuroprotective functions beyond its recognized effects on allergy, histamine, might have a renewed and far-reaching momentum in ALS.

KW - ALS

KW - Histamine

KW - Microglia

KW - Motor neuron

KW - Neuroinflammation

KW - Personalized medicine

KW - SOD1-G93A

UR - http://www.scopus.com/inward/record.url?scp=85068060538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068060538&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2019.06.006

DO - 10.1016/j.pharmthera.2019.06.006

M3 - Review article

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

ER -